Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres

被引:121
作者
Araujo, J. [2 ]
Vega, E. [2 ]
Lopes, C. [1 ,3 ]
Egea, M. A. [2 ]
Garcia, M. L. [2 ]
Souto, E. B. [1 ,3 ]
机构
[1] Fernando Pessoa Univ, Fac Hlth Sci, Dept Pharmaceut Technol, P-4200150 Oporto, Portugal
[2] Univ Barcelona, Fac Pharm, Inst Nanosci & Nanotechnol, Dept Phys Chem, E-08028 Barcelona, Spain
[3] Univ Tras Os Montes & Alto Douro, Ctr Genet & Biotechnol, Inst Biotechnol & Bioengn, P-5000801 Vila Real, Portugal
关键词
Flurbiprofen; Poly(lactic-co-glycolic) acid (PLGA); Inherent viscosity; Nanospheres; Ocular administration; HET-CAM; DRUG-DELIVERY; NANOPARTICLES; RELEASE; MICROPARTICLES; FORMULATION; NANOPRECIPITATION; EMULSION; BEHAVIOR; CARRIERS; DEVICES;
D O I
10.1016/j.colsurfb.2009.03.028
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Poly(lactide-co-glycolide) acid (PLGA) nanospheres incorporating flurbiprofen (FB) were produced by the solvent displacement technique, for ocular applications aiming to avoid/minimize inflammation induced by surgical trauma. In this work. a PLGA of low viscosity has been tested and the results obtained were compared with those previously reported by Vega et al. The physicochemical properties of the developed formulations were evaluated by measuring particle size, zeta potential and FB entrapment efficiency, showing no significant differences. Release studies demonstrated that the formulation produced with PLGA of higher viscosity revealed a slower drug release rate. Stability analysis, for a period of 75 days, was performed using three complementary methods: (i) turbidity experiments using a Turbiscan optical analyzer, (ii) particle size measurements, and (iii) zeta potential analysis. The results revealed long-term physicochemical stability suitability for ophthalmic use, being independent from the polymer viscosity. The ocular tolerance was assessed by an alternative in vitro method to animal experimentation, the HET-CAM. For all developed formulations no ocular irritancy has been detected. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 44 条
[1]   Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration [J].
Ahlin, P ;
Kristl, J ;
Kristl, A ;
Vrecer, F .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 239 (1-2) :113-120
[2]   DETERMINATION OF IBUPROFEN IN CAPILLARY AND VENOUS PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION [J].
ALBERT, KS ;
RAABE, A ;
GARRY, M ;
ANTAL, EJ ;
GILLESPIE, WR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (10) :1487-1489
[3]  
[Anonymous], 1978, STAT EXPT INTRO DESI
[4]   Chitosan based nanocarriers for indomethacin ocular delivery [J].
Badawi, Alia A. ;
El-Laithy, Hanan M. ;
El Qidra, Riad K. ;
El Mofty, Hala ;
El Dally, Mohamed .
ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (08) :1040-1049
[5]   Prevention of topical and ocular oxidative stress by positively charged submicron emulsion [J].
Benita, S .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (04) :193-206
[6]   In vitro evaluation of poly(D,L-lactide-co-glycolide) polymer-based implants containing the alpha-melanocyte stimulating hormone analog, Melanotan-I [J].
Bhardwaj, R ;
Blanchard, J .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (01) :49-55
[7]   RECENT ADVANCES ON THE USE OF BIODEGRADABLE MICROPARTICLES AND NANOPARTICLES IN CONTROLLED DRUG-DELIVERY [J].
BRANNONPEPPAS, L .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (01) :1-9
[8]  
Chiappetta D, 2005, ARS PHARM, V46, P383
[9]  
Deshpande AA, 1998, CRIT REV THER DRUG, V15, P381
[10]   The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles [J].
Dillen, K ;
Weyenberg, W ;
Vandervoort, J ;
Ludwig, A .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (03) :539-549